GL1X · GenesisL1 explorer

MolNFT v1 · #55612 · protein

Human insulin degrading enzyme E111Q in complex with inhibitor compound 41367

2YPU · Insulin-degrading enzyme: “Human insulin degrading enzyme E111Q in complex with inhibitor compound 41367”. X-ray diffraction, 2 ligands (I41, ZN), 20 pockets (best druggability 0.85). MolNFT v1 #55612 on GenesisL1: 3D structure…

PDB
2YPU
Type
protein
Length
1,910 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Insulin-degrading enzyme
EC
3.4.24.56
UniProt
P14735
Ligands
I41, ZN
Pockets
20 · best druggability 0.85

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInsulin-degrading enzyme (EC 3.4.24.56)protein95644% helix, 20% strandP14735
BInsulin-degrading enzyme (EC 3.4.24.56)protein95445% helix, 20% strandP14735

Ligands and binding sites

  • I41 · 2-[[2-[[(2S)-3-(3H-imidazol-4-yl)-1-methoxy-1-oxo-propan-2-yl]amino]-2-oxo-ethyl]-(phenylmethyl)amino]ethanoic acid · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 12 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110220.850.8699empty
28450.750.79117ZN
37120.720.7995empty
45080.700.8072empty
53500.660.8143empty

Interfaces

1 interface between chains.

  • A–B · 1578 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 2YPU · human insulin degrading enzyme E111Q in complex with inhibitor compound 41367 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.